Bone Density and Aromatase Inhibitors
The Devil and the Details Today was a four month visit with my oncologist after my second diagnosis of breast cancer one year ago. One of the purposes of the visit was to discuss bone loss while on Arimidex, the Aromatase Inhibitor I will be taking for ten years, unless of course they come up with something new between now and then. I was diagnosed with both invasive and in situ lobular carcinoma (LCIS) in my left breast twelve years ago. After two lumpectomies to achieve clear margins, eighteen weeks of chemotherapy and six weeks of daily radiation I took Tamoxifen for five years. Last year I had a recurrence of LCIS in the left breast and a new and different cancer, ductal carcinoma in situ (DCIS), in the right breast. Because of the new cancer in the right breast and the fact I had a recurrence in the left Continue Reading →